The San Diego facility will support further developing Vividion's global research and clinical portfolio and pave the way for future programs to deliver best-in-class...

Bayer and Charité - Universitätsmedizin Berlin recently unveiled plans to establish the Berlin Center for Gene and Cell Therapies, a translational center for gene and...

A growing and aging world population and the increasing strain on nature’s ecosystems are among the major challenges facing humanity.

Artificial intelligence (AI) can help companies in the process industry capture, retain and access valuable historical expertise and ease the transition for new...

Bayer and RTW Investments have announced an equity investment in Jixing Pharmaceuticals of €32 million ($35 million) and €116 million ($127 million) respectively.

Iktos, a French company specialized in artificial intelligence (AI) for new drug design, and Bayer’s Crop Science division announced a collaboration to expand the use of...

Berlin Mayor Kai Wegner and Bayer's Stefan Oelrich unveil a high-tech facility as part of a global billion-euro investment initiative. The advanced space, featuring a...

Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was...